R&D

21세기를 주도하는 바이오 업계의 선두주자가 되기 위해 항상 최선을 다하는 기업

  • 논문

    국가과제

    특허출원

    • 번호
    • 구분
    • 논문명
    • 년도

    No.13

    Optimal device and method for transportation of isolated porcine islet

    Islet

    Optimal device and method for transportation of isolated porcine islet

    2013

    No.12

    A Therapeutic Strategy for Metastatic Malignant Fibrous Histiocytoma Through Mesenchymal Stromal Cell-Mediated TRAIL Production.

    MSC

    A Therapeutic Strategy for Metastatic Malignant Fibrous Histiocytoma Through Mesenchymal Stromal Cell-Mediated TRAIL Production.

    2013

    No.11

    Systemic human T cell developmental processes in humanized mice cotransplanted with human fetal thymus/liver tissue and hematopoietic stem cells.

    Hu-mouse

    Systemic human T cell developmental processes in humanized mice cotransplanted with human fetal thymus/liver tissue and hematopoietic stem cells.

    2012

    No.10

    Enhancement of the immunosuppressive effect of human adipose tissue-derived mesenchymal stromal cells through HLA-G1 expression.

    MSC

    Enhancement of the immunosuppressive effect of human adipose tissue-derived mesenchymal stromal cells through HLA-G1 expression.

    2012

    No.9

    In situ induction of dendritic cell–based T cell tolerance in humanized mice and nonhuman primates

    Hu-mouse

    In situ induction of dendritic cell–based T cell tolerance in humanized mice and nonhuman primates

    2011

    No.8

    Co-transplantation of fetal bone tissue facilitates the development and reconstitution in human B cells in humanized NOD/SCID/IL-2Rγnull (NSG) mice.

    Hu-mouse

    Co-transplantation of fetal bone tissue facilitates the development and reconstitution in human B cells in humanized NOD/SCID/IL-2Rγnull (NSG) mice.

    2011

    No.7

    Improved quantification of islet transplants by magnetic resonance imaging with resovist.

    Islet

    Improved quantification of islet transplants by magnetic resonance imaging with resovist.

    2011

    No.6

    The effect of human fetal liver-derived mesenchymal stem cells on CD34(+) hematopoietic stem cell repopulation in NOD/Shi-scid/IL-2Rã(null) mice.

    Hu-mouse

    The effect of human fetal liver-derived mesenchymal stem cells on CD34(+) hematopoietic stem cell repopulation in NOD/Shi-scid/IL-2Rã(null) mice.

    2011

    No.5

    Human B Cell Development and Antibody Production in Humanized NOD/SCID/IL-2Rγnull (NSG) Mice Conditioned by Busulfan.

    Hu-mouse

    Human B Cell Development and Antibody Production in Humanized NOD/SCID/IL-2Rγnull (NSG) Mice Conditioned by Busulfan.

    2011

    No.4

    Human T cell development in the liver of humanized NOD/SCID/IL-2R(NSG) mice generated by intrahepatic injection of CD34+ human(h) cord blood(CB) cells.

    Hu-mouse

    Human T cell development in the liver of humanized NOD/SCID/IL-2R(NSG) mice generated by intrahepatic injection of CD34+ human(h) cord blood(CB) cells.

    2011

    No.3

    AFT024 cell line in co-culture system using high pore density insert (HPDI) maintains hematopoietic stem/progenitor cells (HSCs/HPCs) as more primitive state through histone modification.

    MSC

    AFT024 cell line in co-culture system using high pore density insert (HPDI) maintains hematopoietic stem/progenitor cells (HSCs/HPCs) as more primitive state through histone modification.

    2010

    No.2

    Cartilage oligomeric matrix protein-angiopoientin-1 enhances angiogenesis of isolated islet and maintains normoglycemia following transplantation.

    Islet

    Cartilage oligomeric matrix protein-angiopoientin-1 enhances angiogenesis of isolated islet and maintains normoglycemia following transplantation.

    2010

    No.1

    Trophic molecules derived from human mesenshymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation.

    Islet

    Trophic molecules derived from human mesenshymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation.

    2010

    • 번호
    • 사업명
    • 연구과제명
    • 관리기관
    • 연구기간

    No. 1

    이종이식제제 관리기준 마련 - 원료동물의 관리 및 이종이식제제 품질평가법 개발 연구

    2022년 1차 용역연구개발과제

    이종이식제제 관리기준 마련 - 원료동물의 관리 및 이종이식제제 품질평가법 개발 연구

    식품의약품안전처

    2022-02-01~2023-11-30

    No. 2

    코로나19 DNA 백신 GX-19N의 임상1/2a상 개발 및 임상 2b/3상 승인

    코로나19 백신 임상지원

    코로나19 DNA 백신 GX-19N의 임상1/2a상 개발 및 임상 2b/3상 승인

    범부처신약개발사업단

    2020-09-15~2021-09-14

    No. 3

    메타 소프트오간모듈 제작 기술 및 모듈 어셈블리 로봇 시스템 개발

    2020년도 산업기술 알키미스트 프로젝트

    메타 소프트오간모듈 제작 기술 및 모듈 어셈블리 로봇 시스템 개발

    산업통상자원부

    2020-09-01~2022-02-28

    No. 4

    비감염성질환 예방과 치료를 위한 myostatin 형질전환 소 개발

    기본연구개발사업

    비감염성질환 예방과 치료를 위한 myostatin 형질전환 소 개발

    한국연구재단

    2020-06-01~2023-02-28

    No. 5

    무균/형질전환 돼지의 영장류 이종장기 이식을 통한 이종 장기 임상 적용 가능성 검증

    첨단의료기술개발사업

    무균/형질전환 돼지의 영장류 이종장기 이식을 통한 이종 장기 임상 적용 가능성 검증

    보건복지부

    2020-04-23~2022-12-31

    No. 6

    PD-L1에 hyFc 영역을 포함하는 신규 면역억제제 개발 및 사업화

    2020상반기 IP-R&D 전략사업

    PD-L1에 hyFc 영역을 포함하는 신규 면역억제제 개발 및 사업화

    한국특허전략개발원

    2020-04-13~2020-09-28

    • 번호
    • 년도
    • 특허명